Abstract：
Ischemic cardiomyopathy (ICM) is the most common underlying etiology of heart failure in the United States and is a significant contributor to deaths due to cardiovascular disease worldwide. The diagnosis and management of ICM has advanced significantly over the past few decades, and the evidence for medical therapy in ICM is both compelling and robust. This contrasts with evidence for coronary revascularization, which is more controversial and favors surgical approaches. This review will examine landmark clinical trial results in detail as well as provide a comprehensive overview of the current epidemiology, diagnostic approaches, and management strategies of ICM.
摘要：
缺血性心肌病（ICM）是美国心力衰竭最常见的潜在病因，是全球心血管疾病导致死亡的重要原因。在过去的几十年中，ICM的诊断和管理取得了显着进步，ICM中药物治疗的证据既令人信服又有力。这与冠状动脉血运重建的证据相反，这是更有争议的，有利于手术方法。这篇综述将详细审查具有里程碑意义的临床试验结果，并提供当前流行病学的全面概述，诊断方法，以及ICM的管理策略。
